Bismuth Subsalicylate
NDC Package 70166-059-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Bismuth Subsalicylate is shake well before usefor accurate dosing, use dose cupadults and children 12 years and over: 1 dose (2 tbsp or 30 mL) every 1/2 to 1 hour as neededdo not exceed 8 doses (16 tbsp or 240 mL) in 24 hoursuse until diarrhea stops but not more than 2 dayschildren under 12 years: ask a doctordrink plenty of clear fluids to help prevent dehydration caused by diarrhea. Marketed by Lohxa, this product is identified by NDC 70166-059 and is authorized under FDA application part335.

Identification & Billing

NDC Package Code
70166-059-01
Package Description
50 CUP, UNIT-DOSE in 1 CARTON / 15 mL in 1 CUP, UNIT-DOSE
Product Code
11-Digit Billing Format
70166005901
RxNorm Crosswalk
  • RxCUI: 308762 - bismuth subsalicylate 525 MG in 30 mL Oral Suspension
  • RxCUI: 308762 - bismuth subsalicylate 17.5 MG/ML Oral Suspension
  • RxCUI: 308762 - bismuth subsalicylate 1.75 % Oral Suspension
  • RxCUI: 308762 - bismuth subsalicylate 262 MG per 15 ML Oral Suspension
  • RxCUI: 308762 - bismuth subsalicylate 524 MG per 30 ML Oral Suspension

Clinical Specifications

Proprietary Name
Bismuth Subsalicylate
Dosage Form
-
Usage Information
Shake well before usefor accurate dosing, use dose cupadults and children 12 years and over: 1 dose (2 tbsp or 30 mL) every 1/2 to 1 hour as neededdo not exceed 8 doses (16 tbsp or 240 mL) in 24 hoursuse until diarrhea stops but not more than 2 dayschildren under 12 years: ask a doctordrink plenty of clear fluids to help prevent dehydration caused by diarrhea

Regulatory & Marketing

Labeler Name
Lohxa
FDA Application #
part335
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
05-30-2008
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70166-059-01 identifies a specific commercial package of 50 cup, unit-dose in 1 carton / 15 ml in 1 cup, unit-dose of Bismuth Subsalicylate, labeled by Lohxa. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Lohxa on May 30, 2008. The current certification is valid through December 31, 2022.

How is this Lohxa product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70166005901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70166-059-01
11-Digit CMS (5-4-2)
70166-0059-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.